ArticleScientific reports2025

Vildagliptin modulates the microbiota and induces an immunometabolic profile compatible with neuroprotection in type 2 diabetes.

Juliane Colombo Carrer de Macedo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.